Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Annovis Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +5 vs. Q4 2024
- Shares held
- 2.09M
- +511.3K (+32.5%) vs. Q4 2024
- Total value
- $3.13M
- −$4.80M (−60.5%) vs. Q4 2024
- New holders
- 13
- 16 more added
- Sold out
- 8
- 4 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 2 | $3 | 0.00% | +2 | New |
| Bank of America Corp | 136 | $204 | 0.00% | +52+61.9% | Added |
| Larson Financial Group LLC | 150 | $225 | 0.00% | +150 | New |
| Game Plan Financial Advisors, LLC | 200 | $300 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 350 | $525 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 360 | $540 | 0.00% | +360 | New |
| Bokf, NA | 555 | $833 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 602 | $903 | 0.00% | +100+19.9% | Added |
| DiNuzzo Private Wealth, Inc. | 1,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.50K | 0.00% | +1,000 | New |
| SBI Securities Co., Ltd. | 1,440 | $2.16K | 0.00% | +1,037+257.3% | Added |
| Tower Research Capital LLC (TRC) | 1,784 | $2.68K | 0.00% | +16+0.9% | Added |
| Covestor Ltd | 1,876 | $3.00K | 0.00% | +1,876 | New |
| JPMorgan Chase & Co | 8,800 | $13.2K | 0.00% | +5,000+131.6% | Added |
| Bryn Mawr Trust Co | 9,393 | $14.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,746 | $14.6K | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,050 | $15.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,189 | $15.3K | 0.00% | +8,889+683.8% | Added |
| Squarepoint Ops LLC | 12,574 | $18.9K | 0.00% | +12,574 | New |
| JustInvest LLC | 13,214 | $19.8K | 0.00% | +13,214 | New |
| Creative Planning | 13,460 | $20.2K | 0.00% | +3,000+28.7% | Added |
| First National Trust Co | 15,000 | $22.5K | 0.00% | +15,000 | New |
| D. E. Shaw & Co., Inc. | 18,789 | $28.2K | 0.00% | +18,789 | New |
| Bank of New York Mellon Corp | 19,058 | $28.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 19,400 | $29.1K | 0.00% | −2,000−9.3% | Reduced |
| Spears Abacus Advisors LLC | 20,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 20,184 | $30.0K | 0.00% | +20,184 | New |
| Renaissance Technologies LLC | 21,800 | $32.7K | 0.00% | +21,800 | New |
| Sterling Investment Advisors, Ltd. | 23,416 | $35.1K | 0.01% | −558−2.3% | Reduced |
| Lokken Investment Group LLC | 29,235 | $43.9K | 0.02% | +11,000+60.3% | Added |
| State Street Corp | 38,435 | $57.7K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 39,000 | $58.5K | 0.02% | +39,000 | New |
| Northern Trust Corp | 40,679 | $61.0K | 0.00% | +7,899+24.1% | Added |
| Wescott Financial Advisory Group, LLC | 41,607 | $62.4K | 0.01% | 00.0% | Unchanged |
| Greenwich Wealth Management LLC | 46,100 | $69.0K | 0.01% | +14,149+44.3% | Added |
| Group One Trading, L.P. | 50,579 | $75.9K | 0.00% | +24,373+93.0% | Added |
| Two Sigma Advisers, LP | 92,921 | $139.4K | 0.00% | +92,921 | New |
| Merit Financial Group, LLC | 97,816 | $146.7K | 0.00% | −700−0.7% | Reduced |
| BlackRock, Inc. | 100,629 | $150.9K | 0.00% | −11,350−10.1% | Reduced |
| Susquehanna International Group, LLP | 127,705 | $191.6K | 0.00% | +72,393+130.9% | Added |
| Geode Capital Management, LLC | 152,613 | $229.0K | 0.00% | +53,049+53.3% | Added |
| UBS Group AG | 160,876 | $241.3K | 0.00% | +112,140+230.1% | Added |
| Two Sigma Investments, LP | 166,219 | $249.3K | 0.00% | +155,296+1,421.7% | Added |
| Vanguard Group Inc | 647,920 | $971.9K | 0.00% | +181,643+39.0% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −215,207−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −68,107−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −51,347−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −13,002−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,653−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,520−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| WR Wealth Planners, LLC | – | – | – | – | Not filed |